Advent Capital Management Amgen Inc Transaction History

Advent Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1.43 Million - $1.73 Million	5,331 Added 114.18%	10,000 $2.84 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.19 Million - $1.35 Million	4,669 New	4,669 $1.34 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $1.58 Million - $1.93 Million	7,000 New	7,000 $1.69 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $3.46 Million - $3.85 Million	-15,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $2.98 Million - $3.41 Million	15,000 New	15,000 $3.38 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $3,924 - $4,581	-22 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $4,076 - $4,595	22 New	22 $5,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $5.11 Million - $5.74 Million	-30,798 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $5.22 Million - $6.1 Million	30,798 New	30,798 $5.25 Million

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.